Cargando…

PEAβ Triggers Cognitive Decline and Amyloid Burden in a Novel Mouse Model of Alzheimer’s Disease

Understanding the physiopathology of Alzheimer’s disease (AD) has improved substantially based on studies of mouse models mimicking at least one aspect of the disease. Many transgenic lines have been established, leading to amyloidosis but lacking neurodegeneration. The aim of the current study was...

Descripción completa

Detalles Bibliográficos
Autores principales:	Camargo, Luana Cristina, Schöneck, Michael, Sangarapillai, Nivethini, Honold, Dominik, Shah, N. Jon, Langen, Karl-Josef, Willbold, Dieter, Kutzsche, Janine, Schemmert, Sarah, Willuweit, Antje
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8267711/ https://www.ncbi.nlm.nih.gov/pubmed/34209113 http://dx.doi.org/10.3390/ijms22137062

Ejemplares similares

Sex-Related Motor Deficits in the Tau-P301L Mouse Model
por: Camargo, Luana Cristina, et al.
Publicado: (2021)

In Vitro and In Vivo Efficacies of the Linear and the Cyclic Version of an All-d-Enantiomeric Peptide Developed for the Treatment of Alzheimer’s Disease
por: Schemmert, Sarah, et al.
Publicado: (2021)

Comprehensive Characterization of the Pyroglutamate Amyloid-β Induced Motor Neurodegenerative Phenotype of TBA2.1 Mice
por: Dunkelmann, Tina, et al.
Publicado: (2018)

Comparison of the Amyloid Load in the Brains of Two Transgenic Alzheimer’s Disease Mouse Models Quantified by Florbetaben Positron Emission Tomography
por: Willuweit, Antje, et al.
Publicado: (2021)

In Vitro Potency and Preclinical Pharmacokinetic Comparison of All-D-Enantiomeric Peptides Developed for the Treatment of Alzheimer’s Disease
por: Schartmann, Elena, et al.
Publicado: (2018)

Oral Treatment with d-RD2RD2 Impedes Early Disease Mechanisms in SOD1*G93A Transgenic Mice but Does Not Prolong Survival
por: Wintz, Katharina, et al.
Publicado: (2023)

Aβ Oligomer Elimination Restores Cognition in Transgenic Alzheimer’s Mice with Full-blown Pathology
por: Schemmert, Sarah, et al.
Publicado: (2018)

A Novel Anti-Inflammatory d-Peptide Inhibits Disease Phenotype Progression in an ALS Mouse Model
por: Post, Julia, et al.
Publicado: (2021)

Oral Treatment with RD2RD2 Impedes Development of Motoric Phenotype and Delays Symptom Onset in SOD1(G93A) Transgenic Mice
por: Post, Julia, et al.
Publicado: (2021)

Large-Scale Oral Treatment Study with the Four Most Promising D3-Derivatives for the Treatment of Alzheimer’s Disease
por: Kutzsche, Janine, et al.
Publicado: (2017)

The Aβ oligomer eliminating D-enantiomeric peptide RD2 improves cognition without changing plaque pathology
por: van Groen, Thomas, et al.
Publicado: (2017)

Aβ oligomer concentration in mouse and human brain and its drug-induced reduction ex vivo
por: Kass, Bettina, et al.
Publicado: (2022)

Preclinical Pharmacokinetic Studies of the Tritium Labelled D-Enantiomeric Peptide D3 Developed for the Treatment of Alzheimer´s Disease
por: Jiang, Nan, et al.
Publicado: (2015)

Do We Need Anti-Prionic Compounds to Treat Alzheimer’s Disease?
por: Willbold, Dieter, et al.
Publicado: (2019)

Safety and pharmacokinetics of the orally available antiprionic compound PRI‐002: A single and multiple ascending dose phase I study
por: Kutzsche, Janine, et al.
Publicado: (2020)

Oral treatment with the all-d-peptide RD2 enhances cognition in aged beagle dogs – A model of sporadic Alzheimer’s disease
por: Kutzsche, Janine, et al.
Publicado: (2023)

Stabilization of Monomeric Tau Protein by All D-Enantiomeric Peptide Ligands as Therapeutic Strategy for Alzheimer’s Disease and Other Tauopathies
por: Altendorf, Tim, et al.
Publicado: (2023)

Competitive Mirror Image Phage Display Derived Peptide Modulates Amyloid Beta Aggregation and Toxicity
por: Rudolph, Stephan, et al.
Publicado: (2016)

Correction: Competitive Mirror Image Phage Display Derived Peptide Modulates Amyloid Beta Aggregation and Toxicity
por: Rudolph, Stephan, et al.
Publicado: (2016)

QIAD assay for quantitating a compound’s efficacy in elimination of toxic Aβ oligomers
por: Brener, Oleksandr, et al.
Publicado: (2015)

Metabolic resistance of the D-peptide RD2 developed for direct elimination of amyloid-β oligomers
por: Elfgen, Anne, et al.
Publicado: (2019)

Cryo-EM of Aβ fibrils from mouse models find tg-APP(ArcSwe) fibrils resemble those found in patients with sporadic Alzheimer’s disease
por: Zielinski, Mara, et al.
Publicado: (2023)

High uptake of (68)Ga-PSMA and (18)F-DCFPyL in the peritumoral area of rat gliomas due to activated astrocytes
por: Oliveira, Dennis, et al.
Publicado: (2020)

Amyloid β Oligomeric Species Present in the Lag Phase of Amyloid Formation
por: Wolff, Martin, et al.
Publicado: (2015)

Predicting experimental success: a retrospective case-control study using the rat intraluminal thread model of stroke
por: Liebenstund, Lisa, et al.
Publicado: (2020)

ClC-3 regulates the excitability of nociceptive neurons and is involved in inflammatory processes within the spinal sensory pathway
por: Sierra-Marquez, Juan, et al.
Publicado: (2022)

Corrigendum: ClC-3 regulates the excitability of nociceptive neurons and is involved in inflammatory processes within the spinal sensory pathway
por: Sierra-Marquez, Juan, et al.
Publicado: (2023)

Interference with Amyloid-β Nucleation by Transient Ligand Interaction
por: Zhang, Tao, et al.
Publicado: (2019)

Osteopontin mediates survival, proliferation and migration of neural stem cells through the chemokine receptor CXCR4
por: Rabenstein, Monika, et al.
Publicado: (2015)

Post-stroke treatment with argon preserved neurons and attenuated microglia/macrophage activation long-termly in a rat model of transient middle cerebral artery occlusion (tMCAO)
por: Liu, Jingjin, et al.
Publicado: (2022)

Application of an Amyloid Beta Oligomer Standard in the sFIDA Assay
por: Kühbach, Katja, et al.
Publicado: (2016)

Osteopontin Augments M2 Microglia Response and Separates M1- and M2-Polarized Microglial Activation in Permanent Focal Cerebral Ischemia
por: Ladwig, Anne, et al.
Publicado: (2017)

Monomeric Amyloid Beta Peptide in Hexafluoroisopropanol Detected by Small Angle Neutron Scattering
por: Zhang-Haagen, Bo, et al.
Publicado: (2016)

Investigation of Cerebral O-(2-[(18)F]Fluoroethyl)-L-Tyrosine Uptake in Rat Epilepsy Models
por: Stegmayr, Carina, et al.
Publicado: (2020)

Optimization of the All-D Peptide D3 for Aβ Oligomer Elimination
por: Klein, Antonia Nicole, et al.
Publicado: (2016)

Progress towards structural understanding of infectious sheep PrP-amyloid
por: Müller, Henrik, et al.
Publicado: (2014)

Post-stroke treatment with argon attenuated brain injury, reduced brain inflammation and enhanced M2 microglia/macrophage polarization: a randomized controlled animal study
por: Liu, Jingjin, et al.
Publicado: (2019)

β-Hairpin of Islet Amyloid Polypeptide Bound to an Aggregation Inhibitor
por: Mirecka, Ewa A., et al.
Publicado: (2016)

Structural basis for the inhibition of IAPP fibril formation by the co-chaperonin prefoldin
por: Törner, Ricarda, et al.
Publicado: (2022)

Fluorescence correlation spectroscopy reveals a cooperative unfolding of monomeric amyloid-β 42 with a low Gibbs free energy
por: Schneider, Mario, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_2htsdeu6nfu8qgooa30to3endl